Skip to content

Clinical trials

Phase 1 HIV Infections trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: HIV Infections Phase: Phase 1 Clear all

857 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20008
20013
20027
200316
200422
200527
200636
200736
200826
200944
201029
201125
20128
201311
201415
201518
201615
201722
201816
201920
202016
202114
202213
20238
202413
202511
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed745
Terminated34
Unknown status26
Withdrawn23
Active, not recruiting14
Recruiting10
Not yet recruiting3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)363
ViiV Healthcare63
National Cancer Institute (NCI)17
Bristol-Myers Squibb16
International AIDS Vaccine Initiative15
Boehringer Ingelheim12
International Partnership for Microbicides, Inc.12
Merck Sharp & Dohme LLC11
Tibotec Pharmaceuticals, Ireland11
Gilead Sciences9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
HIV Infections857
Acquired Immunodeficiency Syndrome242
AIDS-Related Complex100
Sarcoma, Kaposi23
AIDS-Related Opportunistic Infections21
Pregnancy Complications, Infectious16
Infections15
Vaccinia14
Cytomegalovirus Infections12
Virus Diseases11

Trials

Showing 51 to 75 of 857. Each trial links to its page on Pharma Observatory.

757 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.